Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial

Fig. 3

TFRD in cohort 2. TFRD for patients who received regimens (a) including S-1 and those who received regimens not including S-1 after recurrence (both treatment groups combined), (b) including S-1 and those who received regimens not including S-1 after recurrence (adjuvant S-1 group) and (c) including S-1 and those who received regimens not including S-1 after recurrence (surgery-only group)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us